Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia.

about

Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia.

Item

http://www.wikidata.org/entity/Q42694880

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Adherence to tyrosine kinase i ...... with chronic myeloid leukemia.

@en

Adherence to tyrosine kinase i ...... with chronic myeloid leukemia.

@nl

type

Item

label

Adherence to tyrosine kinase i ...... with chronic myeloid leukemia.

@en

Adherence to tyrosine kinase i ...... with chronic myeloid leukemia.

@nl

prefLabel

Adherence to tyrosine kinase i ...... with chronic myeloid leukemia.

@en

Adherence to tyrosine kinase i ...... with chronic myeloid leukemia.

@nl

P1476

Adherence to tyrosine kinase i ...... with chronic myeloid leukemia.

@en

P2093

Bo Zhao

http://www.w3.org/2001/XMLSchema#string

Lei Liu

http://www.w3.org/2001/XMLSchema#string

Ya-Chen Tina Shih

http://www.w3.org/2001/XMLSchema#string

P2860

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer

Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review

Adherence to therapy with oral antineoplastic agents

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia.

Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.

Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement.

Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.

Long-term outcomes in the second-line treatment of chronic myeloid leukemia: a review of tyrosine kinase inhibitors

The effect of incentive-based formularies on prescription-drug utilization and spending.

P304

364-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.31050

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Chan Shen

P577

2017-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28976559

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

5764158

http://www.w3.org/2001/XMLSchema#string